Healthcare News - An Overview
Novo CEO pressed by Senate to cut selling prices of obesity, diabetic issues drugs CEO Lars Fruergaard Jørgensen explained to lawmakers the corporation would think about new talks with insurers with regards to the record selling prices of Wegovy and copyright if they pledge to keep the medicines on their formularies.Sanders swiftly condemned the t